Review
doi: 10.1016/j.cca.2012.05.009.
Epub 2012 May 16.
Interleukin 6 and C-reactive protein in esophageal cancer
Affiliations
- PMID: 22609487
- DOI: 10.1016/j.cca.2012.05.009
Item in Clipboard
Review
Interleukin 6 and C-reactive protein in esophageal cancer
Clin Chim Acta.
.
Abstract
Esophageal cancer (EC) is one of the most aggressive malignant tumors of the gastrointestinal tract. It is well known that cancer initiation and tumor development are closely linked with inflammation. C-reactive protein (CRP) and interleukin-6 (IL-6) are acute-phase proteins involved in cancer development. It was suggested that CRP and IL-6 play potential roles in the growth and progression of malignant tumors, including EC. The aim of the study was to describe the significance of IL-6 and CRP in the development of esophageal cancer and to assess the potential role of their serum levels as prognostic indicators of EC patient's survival.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
-
Elevated serum CRP levels after induction chemoradiotherapy reflect poor treatment response in association with IL-6 in serum and local tumor site in patients with advanced esophageal cancer.J Surg Oncol. 2011 Jan 1;103(1):62-8. doi: 10.1002/jso.21751. J Surg Oncol. 2011. PMID: 21031427
-
Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma.J Surg Oncol. 2003 Aug;83(4):248-52. doi: 10.1002/jso.10275. J Surg Oncol. 2003. PMID: 12884238
-
C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer.J Am Coll Surg. 2009 Oct;209(4):477-83. doi: 10.1016/j.jamcollsurg.2009.06.365. Epub 2009 Aug 8. J Am Coll Surg. 2009. PMID: 19801321
-
Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer.Crit Rev Clin Lab Sci. 2011 Jul-Aug;48(4):155-70. doi: 10.3109/10408363.2011.599831. Crit Rev Clin Lab Sci. 2011. PMID: 22035340 Review.
-
Novel diagnostic and prognostic biomarkers in esophageal cancer.Expert Opin Med Diagn. 2013 Nov;7(6):557-71. doi: 10.1517/17530059.2013.843526. Epub 2013 Oct 4. Expert Opin Med Diagn. 2013. PMID: 24093836 Review.
Cited by
-
Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysis.Ther Clin Risk Manag. 2015 Jan 21;11:89-94. doi: 10.2147/TCRM.S70954. eCollection 2015. Ther Clin Risk Manag. 2015. PMID: 25653533 Free PMC article. Review.
-
Post-diagnostic C-reactive protein and albumin predict survival in Chinese patients with non-small cell lung cancer: a prospective cohort study.Sci Rep. 2019 May 31;9(1):8143. doi: 10.1038/s41598-019-44653-x. Sci Rep. 2019. PMID: 31148582 Free PMC article.
-
A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma.PLoS One. 2015 Sep 21;10(9):e0138657. doi: 10.1371/journal.pone.0138657. eCollection 2015. PLoS One. 2015. PMID: 26390126 Free PMC article.
-
Effects of s-ketamine combined with sevoflurane anesthesia on postoperative cellular immune function and inflammatory response in radical esophageal cancer surgery: A double-blind randomized trial.Medicine (Baltimore). 2025 Jun 20;104(25):e42962. doi: 10.1097/MD.0000000000042962. Medicine (Baltimore). 2025. PMID: 40550017 Free PMC article. Clinical Trial.
-
Effect of early enteral nutrition on postoperative nutritional status and immune function in elderly patients with esophageal cancer or cardiac cancer.Chin J Cancer Res. 2013 Jun;25(3):299-305. doi: 10.3978/j.issn.1000-9604.2013.06.01. Chin J Cancer Res. 2013. PMID: 23825906 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
